An investigation into illegal cigarette factories in Latvia has revealed operations generating millions in revenue. Authorities discovered unsanitary conditions, including rat urine, in the tobacco used for production.

Delfi: Millions from one truck: Discussion on illegal cigarette factories in Latvia

An investigation into illegal cigarette production facilities in Latvia reveals millions in revenue and the presence of rat urine in the tobacco.

A group of private bondholders of the airline airBaltic has publicly expressed their dissatisfaction with the company's current financial situation.

Delfi: Several private airBaltic bondholders and bondholder group dissatisfied

A group of private bondholders for the airline airBaltic are expressing their dissatisfaction with the company's financial situation.

Economist Pēteris Strautiņš highlighted how a 'small-time vendor' mentality has negatively impacted Latvia's economy and outlined necessary reforms for the government to address business environment challenges.

IR: What Latvians Can and Cannot Do: Conversation with Economist Pēteris Strautiņš

Economist Pēteris Strautiņš explains how the economy has suffered from a 'small-time vendor' mentality in Latvia's business environment and what reforms should be demanded from the government.

The retail sector is undergoing significant changes with the widespread adoption of self-checkout systems and the emerging trend of stores operating entirely without cashiers, along with an expanded range of products in vending machines.

IR: Store Without a Cashier

Retail is undergoing significant changes, with self-checkout widely adopted and now the emergence of stores without cashiers and a broader range of products available in vending machines.

Latvian startup PrintyMed is making advancements in medical technology by developing biomaterials from artificial spider silk for the creation of artificial organs, with a membrane-on-a-chip product slated for market release.

IR: Dream of Artificially Created Organs

Latvian startup PrintyMed develops biomaterials for medicine from artificial spider silk, with membrane-on-a-chip being their closest product for market launch, and their CEO's long-term dream could revolutionize future medicine.